Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 2/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | HRH1 | P35367 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.41 |
| ▸ | DPP4 | P27487 | 2/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.41 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.40 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6495673 | 0.84 | MEN1 (0.49) | L3MBTL1HPGDTSHRFKBP1ADPP4 | |
| SCHEMBL6491848 | 0.82 | LTA4H (0.65) | L3MBTL1ACHELTA4HCYP2D6HRH1 | |
| SCHEMBL596252 | 0.78 | L3MBTL1 (0.96) | L3MBTL1ACHEHRH3CYP2D6KCNH2 | |
| SCHEMBL4585565 | 0.78 | LTA4H (0.60) | ACHELTA4HCYP2D6KCNH2 | |
| SCHEMBL6223173 | 0.77 | LTA4H (0.59) | L3MBTL1ACHELTA4HCYP2D6HRH1 | |
| SCHEMBL7269112 | 0.77 | L3MBTL1 (1.00) | L3MBTL1ACHEHRH3KCNH2APP | |
| SCHEMBL1626076 | 0.77 | L3MBTL1 (1.00) | L3MBTL1ACHEHRH3KCNH2APP | |
| SCHEMBL9212361 | 0.77 | L3MBTL1 (1.00) | L3MBTL1ACHEHRH3KCNH2APP | |
| SCHEMBL610772 | 0.77 | L3MBTL1 (1.00) | L3MBTL1ACHEHRH3KCNH2APP | |
| Hydrochloric Acid SCHEMBL12494696 | 0.75 | L3MBTL1 (0.97) | L3MBTL1ACHEHRH3KCNH2APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6949550-B2 | Substituted amino methyl factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-09-27 | — | — | US | disclosed |
| US-20030212054-A1 | Substituted amino methyl factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2003-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030212054-A1 | Substituted amino methyl factor Xa inhibitors | F11, F10, F9 | L3MBTL1 1605/4885ACHE 2499/4885LTA4H 3522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.